Patent 11242367 was granted and assigned to Silk Technologies, Ltd. on February, 2022 by the United States Patent and Trademark Office.
Described herein are methods for reducing inflammation by administration of an effective amount of silk-derived proteins (SDP) or a fraction thereof to a subject having an inflammatory condition. The methods include the treatment of inflammatory conditions and wounds, including corneal wounds, comprising the topical administration of an effective amount of SDP material as described herein.